The Monoselective Sphingosine-1-Phosphate Receptor-1 Modulator Ponesimod Enhances Remyelination in the Cuprizone Model of Demyelination

被引：0
|
作者：
Willems, E. [1 ,2 ]
Schepers, M. [1 ,2 ]
Ait-Tihyaty, M. [3 ]
Vanmierlo, T. [1 ,2 ]
机构：
[1] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium
[2] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands
[3] Janssen Res Dev, Titusville, FL USA
来源：
GLIA | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T14-078C
引用
收藏
页码：E791 / E791
页数：1
相关论文
共 50 条
  • [1] The monoselective sphingosine-1-phosphate receptor-1 modulator ponesimod enhances remyelination in the cuprizone model of demyelination
    Schepers, M.
    Willems, E.
    Ait-Tihyaty, M.
    Vanmierlo, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 631 - 631
  • [2] The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation
    Willems, Emily
    Schepers, Melissa
    Piccart, Elisabeth
    Wolfs, Esther
    Hellings, Niels
    Ait-Tihyaty, Maria
    Vanmierlo, Tim
    FASEB JOURNAL, 2024, 38 (02):
  • [3] Ponesimod, mono-selective sphingosine-1-phosphate receptor 1 modulator enhances oligodendrocyte precursor cell differentiation
    Willems, E.
    Schepers, M.
    Ait-Tihyaty, M.
    Vanmierlo, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 351 - 352
  • [4] Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination
    Kim, SunJa
    Bielawski, Jacek
    Yang, Hyunmin
    Kong, Yu
    Zhou, Beiyan
    Li, Jianrong
    GLIA, 2018, 66 (03) : 654 - 669
  • [5] A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model
    Pan, Shifeng
    Mi, Yuan
    Pally, Charles
    Beerli, Christian
    Chen, Alice
    Guerini, Danilo
    Hinterding, Klaus
    Nuesslein-Hildesheim, Barbara
    Tuntland, Tove
    Lefebvre, Sophie
    Liu, Yi
    Gao, Wenqi
    Chu, Alan
    Brinkmann, Volker
    Bruns, Christian
    Streiff, Markus
    Cannet, Catherine
    Cooke, Nigel
    Gray, Nathanael
    CHEMISTRY & BIOLOGY, 2006, 13 (11): : 1227 - 1234
  • [6] Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model
    Nystad, Agnes E.
    Lereim, Ragnhild Reehorst
    Wergeland, Stig
    Oveland, Eystein
    Myhr, Kjell-Morten
    Bo, Lars
    Torkildsen, Oivind
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 339
  • [7] Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis
    Seyedsadr, Maryam S.
    Weinmann, Oliver
    Amorim, Ana
    Ineichen, Benjamin V.
    Egger, Matteo
    Mirnajafi-Zadeh, Javad
    Becher, Burkhard
    Javan, Mohammad
    Schwab, Martin E.
    NEUROBIOLOGY OF DISEASE, 2019, 124 : 189 - 201
  • [8] Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1
    Takuwa, Noriko
    Du, Wa
    Kaneko, Erika
    Okamoto, Yasuo
    Yoshioka, Kazuaki
    Takuwa, Yoh
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (04): : 460 - 481
  • [9] A phase II study of ponesimod, an oral, selective sphingosine 1-phosphate receptor-1 modulator, in chronic plaque psoriasis
    Chimenti, S.
    Arenberger, P.
    Karpati, S.
    Sator, P. -G.
    Vaclavkova, A.
    Burcklen, M.
    Stefani, M.
    D'Ambrosio, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 22 - 22
  • [10] Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke
    Ichijo, Masahiko
    Ishibashi, Satoru
    Li, Fuying
    Yui, Daishi
    Miki, Kazunori
    Mizusawa, Hidehiro
    Yokota, Takanori
    PLOS ONE, 2015, 10 (09):
12345